SCHEMBL772567

SCHEMBL772567

COc1ccc2sc3nc(-c4ccc(N)cc4)cn3c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.63
TP53 P04637 6/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
RAB9A P51151 3/20 0.63
LMNA P02545 2/20 0.63
TSHR P16473 1/20 0.63
ATM Q13315 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
APP P05067 2/20 0.61
RXFP1 Q9HBX9 1/20 0.53
PARP15 Q460N3 1/20 0.51
PARP10 Q53GL7 1/20 0.51
TNKS2 Q9H2K2 1/20 0.51
PARP2 Q9UGN5 1/20 0.51
THRB P10828 2/20 0.48
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 2/20 0.48
GAA P10253 1/20 0.48
NFKB1 P19838 1/20 0.48
GFER P55789 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL772566 0.90 MAPT (0.78) MAPTTP53SMN1; SMN2RAB9ALMNA
Bromide SCHEMBL3867316 0.88 TP53 (0.63) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL3045414 0.88 MAPT (0.63) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL11008475 0.88 MAPT (0.63) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL11015020 0.88 TP53 (0.81) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL3045361 0.86 MAPT (0.61) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL772551 0.86 TP53 (0.61) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL771889 0.86 APP (0.83) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL11035096 0.85 MAPT (0.60) MAPTTP53SMN1; SMN2RAB9ALMNA
SCHEMBL11037810 0.84 LMNA (0.62) MAPTTP53SMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
EP-2218464-A1 Compounds for non-invasive measurement of aggregates of amyloid peptides Technische Universität München (DE) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT MAPT 10/4885TP53 619/4885SMN1; SMN2 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.